Posted on 8/15/16
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Bristol-Myers Squibb's(NYSE:BMY) Opdivo is approved to treat some patients who see their lung cancer return following chemotherapy, but a key trial evaluating Opdivo's use in previously . . .
Posted on 8/15/16
Biotech Forum Daily Digest: Is Biogen Really In Play? Indices Successfully Test Technical Support. Will This Raptor Fly?
"There are many men of principle in both parties in America, but there is no party of principle." - Alexis de Tocqueville Note: To get these . . .
Posted on 8/15/16
Is Berkshire Hathaway In Trouble?
Warren Buffett's Berkshire Hathaway (BRK.A, BRK.B) is commonly known for its two core businesses - railway company Burlington Northern Santa Fe and the insurance operations. And . . .
Posted on 8/14/16
Eleven Biotherapeutics Reports Q2 2016 Financial Results and Provides Strategic Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results for . . .
Posted on 8/14/16
Enumeral Reports Second Quarter Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM), a biotechnology company focused on the discovery and development of novel antibody-based immunotherapies to help the immune system . . .
Posted on 8/12/16
Why ZIOPHARM Oncology's Stock Broke Down in July
IMAGE SOURCE: GETTY IMAGES.What: ZIOPHARM Oncology (NASDAQ:ZIOP), a clinical-stage synthetic immuno-oncology company, lost over 18% of its value last month, according to data from S&P Global . . .
Posted on 8/12/16
RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today reported its financial results for the second . . .
Posted on 8/12/16
Planet Fitness Announces Second Quarter 2016 Results
Planet Fitness, Inc. (NYSE: PLNT) today reported financial results for its second quarter ended June 30, 2016.Second Quarter Fiscal 2016 Highlights Total revenue increased from the . . .
Posted on 8/12/16
Vedanta Biosciences Announces Collaboration with the NYU Langone Medical Center
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, pioneering the development of a novel class of therapies designed to modulate pathways of interaction between the human microbiome and the host . . .
Posted on 8/12/16
Corindus Vascular Robotics and ACIST Medical Systems Collaborate
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, and ACIST Medical Systems, Inc., a Bracco Group company, pioneer . . .
Posted on 8/12/16
Lantheus Holdings Announces Divestiture of Its Australian Radiopharmacy Servicing Business
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of . . .
Posted on 8/11/16
After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers?
IMAGE SOURCE: GETTY IMAGES.Bristol-Myers Squibb's (NYSE:BMY) Opdivo failed to deliver the goods in a key lung cancer trial, causing Bristol-Myers' shares to plummet. The failure also . . .
Posted on 8/11/16
Collegium Reports Second Quarter Financial Results and Provides Corporate Update
CANTON, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today reported its financial results for the second quarter of 2016 and provided a . . .
Posted on 8/11/16
EyeGate Pharmaceuticals Provides Business Update
WALTHAM, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a clinical-stage specialty pharmaceutical company that focuses on developing and commercializing products for treating . . .
Posted on 8/10/16
ImmunoGen, Inc. Gets the FDA Green Light (for Its Trial Design)
IMAGE SOURCE: GETTY IMAGES.ImmunoGen (NASDAQ:IMGN) reported earnings for its fourth fiscal quarter. Now that the company sold its rights to royalty on Roche's Kadcyla, ImmunoGen is . . .
Posted on 8/10/16
Momenta Pharmaceuticals, Inc.: Good News from Courts and the FDA Ahead?
IMAGE SOURCE: GETTY IMAGES.Momenta Pharmaceuticals (NASDAQ:MNTA) released second-quarter earnings last week. While the report included sales of Momenta's and partner Novartis AG's (NYSE:NVS)Glatopa, the generic version . . .
Posted on 8/9/16
U.S. News & World Report Names Hartford Hospital Best in Hartford Metro Region
Hartford Hospital has been ranked #1 in the Hartford region and among the best in Connecticut for 2016-2017 by U.S. News & World Report. The annual . . .
Posted on 8/9/16
Biogen Announces Bioverativ as Name of New Hemophilia-Focused Company
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) today announced that Bioverativ will be the name of the standalone, publicly-traded global biotechnology company that it expects to launch in . . .
Posted on 8/9/16
Sage Therapeutics Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE) today reported business highlights and financial results for the second quarter ended June 30, 2016, and provided an update . . .
Posted on 8/9/16
Selecta Biosciences Provides Corporate Update
WATERTOWN, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, . . .
Posted on 8/9/16
AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
WALTHAM, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the second quarter ended June 30, 2016. . . .
Posted on 8/9/16
Check-Cap Ltd. Announces $5.9 Million Financing
Check-Cap Ltd. (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that . . .
Posted on 8/9/16
IDEXX Laboratories to Host 2016 Investor Day
IDEXX Laboratories, Inc. (NASDAQ: IDXX) will host its 2016 Investor Day on August 17-18, 2016 at its corporate headquarters in Westbrook, Maine. A live audio webcast . . .
Posted on 8/9/16
Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium.The . . .
Posted on 8/9/16
Navidea Executes a Term Sheet with Cerveau Technologies
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announces the execution of a non-binding term sheet with Cerveau Technologies, Inc. (Cerveau) of Boston, MA sublicensing the . . .
Boston
